Preliminary Analysis for Identification of Priority Species of Small Pelagic Shared Stocks in GSA01 And GSA03 (Alborán Sea)

Small pelagic resources and particularly sardine (Sardina pilchardus) and anchovy (Engraulis encrasicholus) represent an important fishery activity for the countries bordering the Alboran Sea. This paper aims at contributing to the identification of priority species of small pelagic shared stocks in GSA01 and GSA03 (northern and southern Alboran Sea GFCM regions) for carrying out joint stock assessments and promoting new management measures that would allow the sustainability of the resources and its exploitation. The WG on small pelagic shared stocks met twice during 2011 progressing in analysing the available data on the stocks and its exploitation and building a common data base. Moreover a comparative analysis on sardine landings data from 2003-2010 in GSA01 and GSA03 was carried out explaining that the exploitation pattern in sub-areas (GSAs 01 and 03) is different but the total length-frequency distribution of sardine exploited by each country appears to be similar. A tentative in applying a LCA analysis of the Moroccan and Spanish data on sardine using different biological parameters and with the VIT software was unsuccessful but orientated for future works of the W

Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

Purpose In the critically ill, hospital-acquired bloodstream infections (HA-BSI) are associated with significant mortality. Granular data are required for optimizing management, and developing guidelines and clinical trials. Methods We carried out a prospective international cohort study of adult patients (≥ 18 years of age) with HA-BSI treated in intensive care units (ICUs) between June 2019 and February 2021. Results 2600 patients from 333 ICUs in 52 countries were included. 78% HA-BSI were ICU-acquired. Median Sequential Organ Failure Assessment (SOFA) score was 8 [IQR 5; 11] at HA-BSI diagnosis. Most frequent sources of infection included pneumonia (26.7%) and intravascular catheters (26.4%). Most frequent pathogens were Gram-negative bacteria (59.0%), predominantly Klebsiella spp. (27.9%), Acinetobacter spp. (20.3%), Escherichia coli (15.8%), and Pseudomonas spp. (14.3%). Carbapenem resistance was present in 37.8%, 84.6%, 7.4%, and 33.2%, respectively. Difficult-to-treat resistance (DTR) was present in 23.5% and pan-drug resistance in 1.5%. Antimicrobial therapy was deemed adequate within 24 h for 51.5%. Antimicrobial resistance was associated with longer delays to adequate antimicrobial therapy. Source control was needed in 52.5% but not achieved in 18.2%. Mortality was 37.1%, and only 16.1% had been discharged alive from hospital by day-28. Conclusions HA-BSI was frequently caused by Gram-negative, carbapenem-resistant and DTR pathogens. Antimicrobial resistance led to delays in adequate antimicrobial therapy. Mortality was high, and at day-28 only a minority of the patients were discharged alive from the hospital. Prevention of antimicrobial resistance and focusing on adequate antimicrobial therapy and source control are important to optimize patient management and outcomes